{"meta":{"query_hash":"7c52c15b5d02","filters":{"venue":"Cancer Drug Resistance"},"cohort_total":12,"direct_labels_cover":0,"predictions_cover":12,"exported":12,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7c52c15b5d02","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Drug+Resistance"},"results":[{"id":"W2898571509","doi":"10.20517/cdr.2018.18","title":"Meeting Abstracts of the BACR conference: response and resistance in cancer therapy","year":2018,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Neuroblastoma; Anaplastic lymphoma kinase; Cancer research; Medicine; Targeted therapy; Oncogene; N-Myc; Cancer; Oncology; Internal medicine; Biology; Lung cancer; Cell cycle; Genetics; Cell culture","score_opus":0.030755088127442792,"score_gpt":0.33808337746355077,"score_spread":0.307328289336108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898571509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736025,0.010928325,6.370786e-7,0.0063098483,0.00015407785,0.00049026625,0.00003277649,0.000017523924,0.00846408],"genre_scores_gemma":[0.9778331,0.003226917,0.00019613496,0.00032367383,0.00008736142,0.00012372684,6.8319133e-7,0.000024148334,0.018184243],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983521,0.00017607778,0.00031585642,0.00037286017,0.00041198512,0.00037108082],"domain_scores_gemma":[0.9987986,0.00020360936,0.00017265363,0.00043450404,0.00026118598,0.00012945604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039363105,0.00017150426,0.0002953705,0.00008166106,0.00012323458,0.000021231235,0.00017800437,0.000053068936,0.00009848444],"category_scores_gemma":[0.0001982216,0.00011767159,0.000052394666,0.00041385874,0.00053135207,0.00007936018,0.00004951176,0.00022303191,0.0000036927258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10344847,0.001185766,0.36656773,0.001660948,0.0005272967,0.00044155316,0.011895439,0.000011963749,0.45619687,0.0012251942,0.045780703,0.011058057],"study_design_scores_gemma":[0.0032171388,0.0000785248,0.82547617,0.0021314637,0.000018413984,0.0000021414855,0.00012947083,0.0000054174957,0.13722341,0.0005060359,0.031069301,0.00014249727],"about_ca_topic_score_codex":0.0003829047,"about_ca_topic_score_gemma":0.019033303,"teacher_disagreement_score":0.45890844,"about_ca_system_score_codex":0.000197297,"about_ca_system_score_gemma":0.0005969497,"threshold_uncertainty_score":0.9988668},"labels":[],"label_agreement":null},{"id":"W2915554719","doi":"10.20517/cdr.2018.21","title":"Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET","year":2018,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Nuclear medicine; Radiation therapy; Voxel; Tumor hypoxia; Glioblastoma; Misonidazole; Hypoxia (environmental); Pet imaging; Positron emission tomography; Medicine; Chemistry; Radiology; Cancer research; Oxygen","score_opus":0.007193521029328238,"score_gpt":0.30235791045602745,"score_spread":0.2951643894266992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915554719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565143,0.0007146227,0.0014005187,0.00592973,0.000031628093,0.00036105086,0.000013939833,0.00011487687,0.0057821968],"genre_scores_gemma":[0.98540336,0.00006916756,0.010730677,0.00032458908,0.00006864423,0.00013882625,0.0000052926425,0.000027506592,0.003231914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998958,0.000016740374,0.00026545275,0.00029110868,0.00022635872,0.00024232236],"domain_scores_gemma":[0.9991817,0.000023244911,0.000119956756,0.00043076015,0.00013848717,0.00010588438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013897511,0.00012691431,0.00026243206,0.00009401728,0.00006677926,0.000009132625,0.00015683075,0.00001503684,0.00017241118],"category_scores_gemma":[0.000018604993,0.00010702012,0.000035890338,0.0003650492,0.0004358166,0.000055483506,0.000031523607,0.00017546667,0.0000052032074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017621486,0.00087601977,0.0894437,0.0015955975,0.0001179847,0.00043720027,0.00194699,0.0000064079313,0.7290486,0.006804205,0.15648331,0.011477815],"study_design_scores_gemma":[0.01132454,0.0005050861,0.18302141,0.014279763,0.00040361742,0.00022715339,0.00113865,0.009264415,0.6196423,0.0074489564,0.1510645,0.0016795894],"about_ca_topic_score_codex":0.00012897309,"about_ca_topic_score_gemma":0.0012023682,"teacher_disagreement_score":0.109406315,"about_ca_system_score_codex":0.0001552329,"about_ca_system_score_gemma":0.00012576558,"threshold_uncertainty_score":0.43641537},"labels":[],"label_agreement":null},{"id":"W2941758788","doi":"10.20517/cdr.2018.24","title":"Pharmacogenetics of asparaginase in acute lymphoblastic leukemia","year":2019,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fondation Charles-Bruneau; Cancer Research Society","keywords":"Pharmacogenetics; Asparaginase; Medicine; Lymphoblastic Leukemia; Acute pancreatitis; Leukemia; Pharmacology; Intensive care medicine; Oncology; Internal medicine; Genotype; Biology; Genetics; Gene","score_opus":0.04136947507326984,"score_gpt":0.37842092036967073,"score_spread":0.3370514452964009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941758788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038734142,0.9934393,0.000052041953,0.000077803816,0.0005604913,0.002067907,0.00040186525,0.000046060602,0.0029671995],"genre_scores_gemma":[0.00023404548,0.9679122,0.00039828985,0.00011011745,0.00026324665,0.00052517134,0.00011274244,0.00020506541,0.0302391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954224,0.00021093874,0.0013984371,0.0010398187,0.0010169796,0.00091142906],"domain_scores_gemma":[0.99675804,0.00063828373,0.0007187884,0.0012523908,0.0002900785,0.00034241725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035789004,0.0007858606,0.003759843,0.00065813045,0.00003740046,0.000023289895,0.00077087746,0.00042568886,0.00028804858],"category_scores_gemma":[0.000146806,0.00067307724,0.0006172514,0.001528176,0.00033148212,0.00007692129,0.00023479348,0.0008559931,0.0002133216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0012521864,0.00026238852,0.0002332469,0.29404724,0.0023497797,0.0022756122,0.00027846545,0.00008654197,0.00007539793,0.00015805855,0.062643334,0.63633776],"study_design_scores_gemma":[0.003199478,0.00003781943,0.0000420123,0.058596153,0.0032361427,0.00007339567,0.000011159881,0.00014196539,0.00013194911,0.000013255457,0.93397784,0.00053881307],"about_ca_topic_score_codex":0.00009318821,"about_ca_topic_score_gemma":0.00009502885,"teacher_disagreement_score":0.87133455,"about_ca_system_score_codex":0.009400125,"about_ca_system_score_gemma":0.015810907,"threshold_uncertainty_score":0.99957204},"labels":[],"label_agreement":null},{"id":"W3010768407","doi":"10.20517/cdr.2019.77","title":"Microfluidic chip enables single-cell measurement for multidrug resistance in triple-negative breast cancer cells","year":2020,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Microfluidic and Capillary Electrophoresis Applications","field":"Engineering","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada; Simon Fraser University; Griffith University","keywords":"Paclitaxel; Multiple drug resistance; Daunorubicin; Drug resistance; Breast cancer; Cancer cell; Efflux; Drug; Cancer; Single-cell analysis; Chemotherapy; Pharmacology; Cancer research; Cell; Liquid biopsy; Intracellular; Medicine; Triple-negative breast cancer; Chemistry; Biology; Internal medicine; Cell biology; Biochemistry","score_opus":0.01725757633327239,"score_gpt":0.21149846755830162,"score_spread":0.19424089122502924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010768407","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.080152325,0.902305,0.003975602,0.005826952,0.000505684,0.0025686445,0.0016380507,0.00043204374,0.002595714],"genre_scores_gemma":[0.71706325,0.27571425,0.00060537923,0.0008125273,0.00045970158,0.0026014203,0.00002592434,0.00019433998,0.002523193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997359,0.00006495328,0.00063320436,0.00074661896,0.0004160974,0.0007801197],"domain_scores_gemma":[0.99883014,0.00009618237,0.00014691343,0.00041366465,0.00025808837,0.00025499184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023092951,0.0004634596,0.0005434317,0.00009804685,0.00018079086,0.000065073546,0.0005001436,0.00012037254,0.00013455746],"category_scores_gemma":[0.000026444279,0.0005114628,0.00016111029,0.00075360155,0.00010651355,0.00016087432,0.00003364076,0.000306709,0.000018598075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023282073,0.000046857913,0.000044828772,0.0005935485,0.000041022708,0.0000025741524,0.00093503506,0.00006606679,0.5826914,0.00008547405,0.41499645,0.000263949],"study_design_scores_gemma":[0.0015721297,0.000008188162,0.00035191255,0.00029481683,0.00004850651,2.645121e-7,0.00018689575,0.00011111664,0.7009738,0.00017487546,0.29575497,0.00052248006],"about_ca_topic_score_codex":0.0001183088,"about_ca_topic_score_gemma":0.0018008401,"teacher_disagreement_score":0.636911,"about_ca_system_score_codex":0.0012132216,"about_ca_system_score_gemma":0.00024956977,"threshold_uncertainty_score":0.9997337},"labels":[],"label_agreement":null},{"id":"W3038775292","doi":"10.20517/cdr.2020.20","title":"Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance","year":2020,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Nanocarriers; Nanomedicine; Nanotechnology; Cancer therapy; Cancer; Multiple drug resistance; Broad spectrum; Drug; Drug resistance; Drug delivery; Medicine; Materials science; Pharmacology; Nanoparticle; Chemistry; Biology; Combinatorial chemistry; Internal medicine","score_opus":0.06664426291510613,"score_gpt":0.2876834602369446,"score_spread":0.22103919732183847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038775292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014122608,0.98489064,0.00027968312,0.00028792772,0.006450229,0.0020557381,0.0014109466,0.0013369096,0.0031467273],"genre_scores_gemma":[0.00008999513,0.97030765,0.0016556546,0.00027314416,0.0013862692,0.0049551874,0.00007009392,0.0009540112,0.020307971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933831,0.000099897334,0.0018366036,0.0017158615,0.001134338,0.0018301886],"domain_scores_gemma":[0.9961377,0.0003494895,0.00053973886,0.0017411158,0.00021725628,0.0010147253],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00032456973,0.0019154969,0.003700383,0.00038220882,0.0004833484,0.0004469964,0.0019570251,0.00036992598,0.00026557324],"category_scores_gemma":[0.0001107907,0.0020178526,0.000972923,0.002653783,0.00018980732,0.00091902236,0.00026451945,0.0016454295,0.0002553233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026845903,0.000031829757,0.000024295976,0.11646986,0.0023551,0.00047729994,0.008471295,0.0034155063,0.00017604393,0.00038108975,0.23450781,0.6334214],"study_design_scores_gemma":[0.00045293674,0.0000046850478,0.0000064411174,0.04104911,0.0006547057,0.0000021718738,0.000091124726,0.000039372248,0.00028671886,0.000103204526,0.9551719,0.0021376563],"about_ca_topic_score_codex":0.00012570822,"about_ca_topic_score_gemma":0.002266064,"teacher_disagreement_score":0.7206641,"about_ca_system_score_codex":0.0058102524,"about_ca_system_score_gemma":0.0014069327,"threshold_uncertainty_score":0.9993589},"labels":[],"label_agreement":null},{"id":"W4285112075","doi":"10.20517/cdr.2022.36","title":"Base excision repair accessory factors in senescence avoidance and resistance to treatments","year":2022,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"DNA damage; Senescence; DNA repair; Biology; Base excision repair; Oxidative stress; Cell biology; Cancer cell; Cancer research; Reactive oxygen species; Cancer; Genetics; DNA; Biochemistry","score_opus":0.04487092346915068,"score_gpt":0.3636242295136351,"score_spread":0.31875330604448443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285112075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0135207055,0.98326015,0.000013818804,0.000078532634,0.00034857463,0.0013779096,0.0004955136,0.0000460403,0.00085875246],"genre_scores_gemma":[0.0005190263,0.9559836,0.00037465754,0.00007552095,0.00019008371,0.0014881942,0.00023957172,0.00014201626,0.040987354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995319,0.0005997752,0.000796659,0.0018999638,0.00063508976,0.0007495312],"domain_scores_gemma":[0.9976928,0.00017531334,0.00034258023,0.0013642414,0.00008521619,0.0003398055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054675963,0.0007291617,0.0012614771,0.00033028502,0.00030321855,0.000059307604,0.0007765489,0.00029521427,0.00010488457],"category_scores_gemma":[0.0003949341,0.0007045458,0.00036529155,0.0009331342,0.00017987627,0.00001776126,0.0005635421,0.0005982199,0.000012422399],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031065627,0.0012646387,0.00285834,0.0868289,0.0012580366,0.0018167684,0.002410281,0.000054823406,0.01108562,0.00017467333,0.3648688,0.52427256],"study_design_scores_gemma":[0.00034113825,0.00003169792,0.000099602854,0.0053646606,0.000074385985,0.0000030408166,0.000051910607,4.4666993e-7,0.0015693768,0.000007604276,0.9917744,0.00068172853],"about_ca_topic_score_codex":0.000097950324,"about_ca_topic_score_gemma":0.0047099805,"teacher_disagreement_score":0.6269056,"about_ca_system_score_codex":0.0011078087,"about_ca_system_score_gemma":0.0008773637,"threshold_uncertainty_score":0.99954057},"labels":[],"label_agreement":null},{"id":"W4285164532","doi":"10.20517/cdr.2022.37","title":"Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer","year":2022,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Liquid biopsy; Breast cancer; Palbociclib; Acquired resistance; Medicine; Oncology; Cancer; Internal medicine; Aromatase inhibitor; Estrogen receptor; Discovery and development of mTOR inhibitors; Circulating tumor cell; Cancer research; Biomarker; Metastatic breast cancer; Biology; Tamoxifen; Signal transduction; PI3K/AKT/mTOR pathway; Metastasis","score_opus":0.013945723214104208,"score_gpt":0.2892108640727782,"score_spread":0.275265140858674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285164532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024864555,0.98955417,0.0000051346697,0.0007731105,0.0009906595,0.0012116726,0.0039433283,0.000026821841,0.0010086615],"genre_scores_gemma":[0.00030993926,0.99007654,0.00017663791,0.00046577357,0.0011867722,0.0023335216,0.00023674432,0.00016456105,0.005049535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656516,0.00015564475,0.0007969348,0.0014604081,0.00033324663,0.0006886177],"domain_scores_gemma":[0.9981576,0.00014864803,0.00038646662,0.000911433,0.00009228381,0.0003035581],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029601456,0.0007098436,0.0012834665,0.00022699372,0.00020037136,0.00009173914,0.0006655882,0.00028953282,0.00017713643],"category_scores_gemma":[0.00013125855,0.0007313774,0.00024370132,0.0006638747,0.00017806802,0.000008696995,0.0005870607,0.0004601476,0.0000058283717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058976905,0.00054765434,0.0005538195,0.042386007,0.0010609266,0.00024635775,0.0010230634,0.00018886192,0.0011876624,0.0006724951,0.5713989,0.37483656],"study_design_scores_gemma":[0.0006027409,0.000045755176,0.00016122173,0.006304005,0.00017306276,0.000005639932,0.000028217193,2.7713332e-7,0.0000715834,0.0000137049765,0.9917778,0.0008160175],"about_ca_topic_score_codex":0.00016853529,"about_ca_topic_score_gemma":0.0077805687,"teacher_disagreement_score":0.42037886,"about_ca_system_score_codex":0.0006486811,"about_ca_system_score_gemma":0.0013209985,"threshold_uncertainty_score":0.99951375},"labels":[],"label_agreement":null},{"id":"W4312464844","doi":"10.20517/cdr.2022.40","title":"Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach","year":2022,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Cancer Centre","funders":"National Cancer Institute","keywords":"Breast cancer; Profiling (computer programming); Medicine; Cancer; Tumor heterogeneity; Broad spectrum; Precision medicine; Acquired resistance; Computational biology; Bioinformatics; Biology; Internal medicine; Pathology; Computer science","score_opus":0.03615936449857441,"score_gpt":0.3235189367208889,"score_spread":0.28735957222231445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312464844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82011855,0.029180015,0.1430675,0.0038147639,0.0012750437,0.000981691,0.00044811255,0.0002616611,0.00085264834],"genre_scores_gemma":[0.98321015,0.00025481678,0.014422008,0.00047593532,0.00015065774,0.0007696259,0.000008361615,0.0000489069,0.0006595628],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99636114,0.0006584015,0.0004807942,0.0011080679,0.0006982091,0.00069340697],"domain_scores_gemma":[0.99857426,0.00018579526,0.00026456622,0.00078122265,0.0000631167,0.0001310239],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005696177,0.00037157533,0.00045153275,0.00026853397,0.00054593175,0.00019201514,0.0011652091,0.000038390906,0.00006729917],"category_scores_gemma":[0.000006427076,0.0003808245,0.00018035239,0.0016011671,0.00008572332,0.00048146135,0.0004185965,0.00030373273,0.0000017091216],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048299835,0.0005350234,0.0093535455,0.000113126116,0.00017531299,0.00008059174,0.0026409146,0.9505252,0.0030996378,0.013903142,0.00017936225,0.018911114],"study_design_scores_gemma":[0.0032123397,0.00005645092,0.054375455,0.00018981658,0.00007982291,0.000068813424,0.00040188117,0.91164243,0.0031791169,0.009550119,0.015699806,0.0015439402],"about_ca_topic_score_codex":0.0016140337,"about_ca_topic_score_gemma":0.0022454278,"teacher_disagreement_score":0.16309156,"about_ca_system_score_codex":0.003552304,"about_ca_system_score_gemma":0.00096478715,"threshold_uncertainty_score":0.99986434},"labels":[],"label_agreement":null},{"id":"W4312557334","doi":"10.20517/cdr.2022.63","title":"Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review","year":2022,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval; Centre hospitalier de l'Université Laval; Hôtel-Dieu de Québec","funders":"Fonds de Recherche du Québec - Santé; Fondation du cancer du sein du Québec; Université Laval","keywords":"Breast cancer; Epigenetics; Oncology; DNA methylation; Cancer; Genetic association; Medicine; Genome-wide association study; Population; Internal medicine; Bioinformatics; Biology; Gene; Genetics; Genotype; Single-nucleotide polymorphism; Gene expression","score_opus":0.011987418497592932,"score_gpt":0.30190014810543225,"score_spread":0.2899127296078393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312557334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013735044,0.96923757,0.000016716298,0.0067448346,0.0001265915,0.00700707,0.0030824994,0.000040030514,0.0000096667945],"genre_scores_gemma":[0.0020678681,0.9872822,0.00023237176,0.0016461656,0.00019980838,0.0066344263,0.00015315281,0.00016753611,0.0016164576],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9942394,0.0013443263,0.0015839756,0.0013096449,0.0007701463,0.00075248955],"domain_scores_gemma":[0.9969532,0.000968304,0.0009127344,0.0005532425,0.00023106832,0.00038147083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008345441,0.00091802335,0.0036670053,0.00062118855,0.00021081646,0.000116473544,0.00031067603,0.00023802627,0.0002513358],"category_scores_gemma":[0.00022516499,0.00084952824,0.00014823546,0.0015328998,0.000111350775,0.00022610922,0.00013864803,0.0007252508,0.000003164956],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015655609,0.0002275013,0.058814496,0.7144088,0.0017687512,0.0001354452,0.012465035,0.00001496601,0.00002737906,0.0000047468407,0.0010524677,0.20951484],"study_design_scores_gemma":[0.0021465588,0.00011542195,0.34200662,0.49698776,0.003561794,0.000063552725,0.00028240235,9.580012e-7,0.0000024267904,0.0000336163,0.15360521,0.0011936706],"about_ca_topic_score_codex":0.0016867964,"about_ca_topic_score_gemma":0.0046581947,"teacher_disagreement_score":0.28319213,"about_ca_system_score_codex":0.0046452754,"about_ca_system_score_gemma":0.001141437,"threshold_uncertainty_score":0.99939555},"labels":[],"label_agreement":null},{"id":"W4382278483","doi":"10.20517/cdr.2023.02","title":"Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors","year":2023,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Context (archaeology); Medicine; Immune checkpoint; Clear cell renal cell carcinoma; Renal cell carcinoma; Disease; Narrative review; Immune system; Immunotherapy; Life expectancy; Oncology; Intensive care medicine; Cancer research; Immunology; Internal medicine; Biology","score_opus":0.0701794746677465,"score_gpt":0.39633057910282576,"score_spread":0.3261511044350793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382278483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027687327,0.99222475,0.0000063144394,0.0018690492,0.00029022407,0.0036500376,0.00024194253,0.00006232561,0.0013784572],"genre_scores_gemma":[0.00014588104,0.983045,0.00087835,0.00010122533,0.00017485116,0.0017978041,0.00021521757,0.00014350718,0.01349816],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934917,0.0005184086,0.0036535119,0.0012544857,0.0005596553,0.0005222305],"domain_scores_gemma":[0.9955422,0.0005475453,0.0018634817,0.0013747285,0.0003694994,0.00030253048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015605093,0.00074936415,0.0046836,0.00035210777,0.00010073748,0.000017016422,0.00034725427,0.0003615267,0.00005191805],"category_scores_gemma":[0.00045416577,0.00060634455,0.0011945034,0.0015218139,0.0003611617,0.00007401264,0.00018078223,0.00094101677,0.00001845536],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039361138,0.00037867646,0.00027746087,0.84884226,0.001245948,0.00045715607,0.00058216735,1.6221087e-7,0.00005683119,0.0021407546,0.023018267,0.122606695],"study_design_scores_gemma":[0.0010162366,0.0000694828,0.0024669038,0.4939533,0.0022802935,0.000020295553,0.00007399912,2.6163036e-7,0.00008669998,0.000452528,0.49907455,0.00050546014],"about_ca_topic_score_codex":0.00009783174,"about_ca_topic_score_gemma":0.0011280496,"teacher_disagreement_score":0.47605628,"about_ca_system_score_codex":0.0013175603,"about_ca_system_score_gemma":0.0018693111,"threshold_uncertainty_score":0.9996388},"labels":[],"label_agreement":null},{"id":"W4407249734","doi":"10.20517/cdr.2024.164","title":"Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance","year":2025,"lang":"en","type":"review","venue":"Cancer Drug Resistance","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immune system; Tumor microenvironment; Cancer cell; Biology; Cancer research; Cancer; Metabolic pathway; Immunology; Metabolism; Biochemistry","score_opus":0.010493319862574207,"score_gpt":0.2897326410551759,"score_spread":0.27923932119260164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407249734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018804503,0.98928565,0.0003960992,0.00018363979,0.002795192,0.0013545125,0.0013786801,0.00005907213,0.004359136],"genre_scores_gemma":[0.000060321065,0.82241696,0.0011509781,0.00014133668,0.001990217,0.0013947636,0.0004984974,0.00018870705,0.17215821],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99380195,0.00039049814,0.0017242412,0.0021162662,0.00052762165,0.0014394403],"domain_scores_gemma":[0.9963072,0.00013551096,0.0011659043,0.0017332855,0.00037742202,0.0002806681],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006593272,0.0013814061,0.0029648822,0.0003957008,0.0002929537,0.00016961711,0.0015659957,0.00044650567,0.00007518186],"category_scores_gemma":[0.00015524698,0.0014167633,0.0010603652,0.0012852653,0.0003746976,0.000023465616,0.00038374396,0.0011563736,0.000013594841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019157914,0.0008432196,0.0005024685,0.17988312,0.0013626129,0.00016141652,0.00064070435,0.00066945545,0.0027582424,0.0029950892,0.18962744,0.6186404],"study_design_scores_gemma":[0.0009024756,0.000006082839,0.00003365946,0.031748287,0.0006015573,0.000006938337,0.00007360264,0.000010005272,0.00077996595,0.000057739537,0.9645438,0.0012358602],"about_ca_topic_score_codex":0.00070290646,"about_ca_topic_score_gemma":0.04382911,"teacher_disagreement_score":0.7749164,"about_ca_system_score_codex":0.0009381414,"about_ca_system_score_gemma":0.0040806844,"threshold_uncertainty_score":0.99989367},"labels":[],"label_agreement":null},{"id":"W4411096079","doi":"10.20517/cdr.2024.208","title":"Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Drug Resistance","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Fibroblast growth factor receptor; Fibroblast growth factor receptor 1; Cancer research; Pediatric cancer; Neuroblastoma; Fibroblast growth factor receptor 4; Cell growth; Cancer; Fibroblast growth factor; Medicine; MAPK/ERK pathway; Receptor; Signal transduction; Biology; Cell culture; Internal medicine; Cell biology; Genetics","score_opus":0.010096935771909017,"score_gpt":0.2835060792571126,"score_spread":0.27340914348520357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411096079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874982,0.008170553,0.0005779832,0.0015803801,0.00009495842,0.0006393151,0.00026446403,0.000011331005,0.0011627763],"genre_scores_gemma":[0.9885396,0.003468109,0.0008190435,0.00008503147,0.000119672026,0.00027231715,0.00003333183,0.00001921266,0.006643726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986274,0.0001355686,0.00030767205,0.00043153536,0.00019831122,0.0002994975],"domain_scores_gemma":[0.99925834,0.000068448215,0.00010185633,0.00039943706,0.00012015329,0.000051738774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113197566,0.00019480094,0.00022170381,0.000113765585,0.00011626078,0.000038190406,0.0002772316,0.00007588684,0.000020941212],"category_scores_gemma":[0.00006569892,0.00015289815,0.00006872635,0.0004090208,0.000115729745,0.0000097348675,0.00004271099,0.00008776713,0.000001698939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011623905,0.0005213606,0.016803874,0.0011864012,0.00016807136,0.000011472701,0.0023831578,0.000039683073,0.93037933,0.01294905,0.03395947,0.0004357469],"study_design_scores_gemma":[0.0023150572,0.00033551815,0.045803167,0.00050608756,0.000042892643,8.398224e-7,0.0005125453,0.000015882297,0.9165206,0.002995865,0.03041014,0.00054141716],"about_ca_topic_score_codex":0.000045281355,"about_ca_topic_score_gemma":0.0026956648,"teacher_disagreement_score":0.028999295,"about_ca_system_score_codex":0.00010049878,"about_ca_system_score_gemma":0.00023451615,"threshold_uncertainty_score":0.6235006},"labels":[],"label_agreement":null}]}